NYSE:AYXAlteryx Stock Price, Forecast & News

Alteryx's stock was trading at $108.54 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, AYX shares have increased by 64.0% and is now trading at $178.02. View which stocks have been most impacted by Coronavirus.

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Alteryx in the last year. There are currently 1 sell rating, 3 hold ratings and 10 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Alteryx.

Alteryx is scheduled to release its next quarterly earnings announcement on Wednesday, July 29th 2020. View our earnings forecast for Alteryx.

Alteryx Inc (NYSE:AYX) released its quarterly earnings data on Wednesday, May, 6th. The company reported ($0.10) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.09) by $0.01. The firm earned $108.80 million during the quarter, compared to analyst estimates of $105.64 million. Alteryx had a return on equity of 7.04% and a net margin of 1.28%. The business's revenue was up 43.2% compared to the same quarter last year. During the same quarter last year, the business posted $0.04 EPS. View Alteryx's earnings history.

Alteryx updated its second quarter 2020 After-Hours earnings guidance on Wednesday, May, 6th. The company provided earnings per share guidance of -0.18--0.12 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $-0.05. The company issued revenue guidance of $91-95 million, compared to the consensus revenue estimate of $107.97 million.

14 equities research analysts have issued 1-year price objectives for Alteryx's stock. Their forecasts range from $88.00 to $216.00. On average, they expect Alteryx's share price to reach $143.33 in the next twelve months. This suggests that the stock has a possible downside of 19.5%. View analysts' price targets for Alteryx.

News headlines about AYX stock have been trending negative recently, according to InfoTrie Sentiment. The research firm rates the sentiment of news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Alteryx earned a news sentiment score of -2.4 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the company's share price in the immediate future. View the latest news about Alteryx.

Some companies that are related to Alteryx include Dassault Systemes (DASTY), Electronic Arts (EA), Veeva Systems (VEEV), Docusign (DOCU), Twilio (TWLO), Splunk (SPLK), Synopsys (SNPS), Datadog (DDOG), Cadence Design Systems (CDNS), Okta (OKTA), ANSYS (ANSS), Atlassian (TEAM), Crowdstrike (CRWD), Coupa Software (COUP) and Citrix Systems (CTXS). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Alteryx investors own include NVIDIA (NVDA), Trade Desk (TTD), salesforce.com (CRM), Alibaba Group (BABA), Shopify (SHOP), Twilio (TWLO), Okta (OKTA), Advanced Micro Devices (AMD), Square (SQ) and Micron Technology (MU).

(AYX) raised $117 million in an IPO on Friday, March 24th 2017. The company issued 9,000,000 shares at a price of $12.00-$14.00 per share. Goldman, Sachs, J.P. Morgan, Barclays and Citigroup served as the underwriters for the IPO and Pacifc iCrest Securities (a division of KeyBanc Capital Markets), William Blair, JMP Securities, Raymond James and Cowen and Company were co-managers.

Alteryx trades on the New York Stock Exchange (NYSE) under the ticker symbol "AYX."

Alteryx's stock is owned by many different institutional and retail investors. Top institutional investors include Carnegie Capital Asset Management LLC (0.13%), Envestnet Asset Management Inc. (0.08%), Whittier Trust Co. (0.02%), Woodstock Corp (0.01%), Whittier Trust Co. of Nevada Inc. (0.01%) and Paragon Advisors LLC (0.01%). Company insiders that own Alteryx stock include Abdiel Capital Management, Llc, Charles Cory, Christopher M Lal, Dean Stoecker, Derek Knudsen, Eileen Schloss, Insight Holdings Group, Llc, Insight Venture Partners Coinv, Insight Venture Partners Viii,, Jeff Horing, Kevin Rubin, Kimberly Alexy, Langley P Eide, Qualified Master Fund L Abdiel, Robert Scott Jones and Timothy I Maudlin. View institutional ownership trends for Alteryx.

AYX stock was sold by a variety of institutional investors in the last quarter, including Woodstock Corp, and Carnegie Capital Asset Management LLC. Company insiders that have sold Alteryx company stock in the last year include Charles Cory, Christopher M Lal, Dean Stoecker, Derek Knudsen, Eileen Schloss, Jeff Horing, Kevin Rubin, Kimberly Alexy, Robert Scott Jones, and Timothy I Maudlin. View insider buying and selling activity for Alteryx.

AYX stock was purchased by a variety of institutional investors in the last quarter, including Envestnet Asset Management Inc., Paragon Advisors LLC, Fulton Breakefield Broenniman LLC, Whittier Trust Co. of Nevada Inc., IBM Retirement Fund, Whittier Trust Co., and Larson Financial Group LLC. View insider buying and selling activity for Alteryx.

Shares of AYX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of AYX stock can currently be purchased for approximately $178.02.

Alteryx has a market capitalization of $11.74 billion and generates $417.91 million in revenue each year. The company earns $27.14 million in net income (profit) each year or $0.56 on an earnings per share basis. Alteryx employs 1,200 workers across the globe.

The official website for Alteryx is www.alteryx.com.

Alteryx's mailing address is 3345 Michelson Drive Suite 400, Irvine CA, 92612. The company can be reached via phone at 888-836-4274 or via email at [email protected]